Page 6 - Science in Africa
P. 6

uarraisha  Abdool  Karim  is  a    Professor  Quarraisha  Abdool  Karim
                      South  African
                      epidemiologist  who  has  had
                      a  profound  impact  on  HIV-
                      prevention  science,  policy
          Qand  programmes  through
                      her  ground-breaking  AIDS
          research,  her  advocacy  and  leadership,
          focused  particularly  on  women  in  Africa.
          One  of  her  major  achievements  has  been
          her  landmark  study  that  demonstrated  that
          tenofovir  gel  prevents  both  HIV  and
          Herpes  Simplex  Virus  Type  2  (HSV-2)
          infection  in  women.
           The  finding  has  been  heralded  as  one  of
          the  most  significant  scientific
          breakthroughs  in  the  fight  against  Aids  by
          the  World  Health  Organisation,  UNAIDS
          and  several  leading  international  research
          organisations.
           This  contribution  to  Aids  prevention
          emerged  as  a  culmination  of  her
          epidemiological,  clinical  and  basic
          research  undertaken  over  more
          than  two  decades  in  South
          Africa.
           In  the  late  1980s,  she
          undertook  some  of  the  first
          studies  to  unravel  the  reasons  for
          the  severity  of  the  Aids  epidemic
          in  southern  Africa.  Her  key  finding,
          that  young  women,
          particularly  teenage  girls,
          were  at  highest  risk  (up
          to  eight-fold  higher  than
          their  male  counterparts),
          set  her  on  the  path  to
          identify  the  biological
          and  behavioural
          reasons  for
          women’s
          vulnerability  to
          HIV.
           Since  young
          women  find  it
          particularly  challenging  to  insist  on  mutual
          monogamy  or  condom  use,  especially  with
          older  male  partners,  Professor  Abdool   Breaking
          Karim  focused  her  research  on  risk-
          reducing  technologies  for  women.
           A  decade  later,  she  changed  her  strategy,
          based  on  interesting  new  data  from  studies
          in  monkeys,  to  trying  an  Aids  treatment
          Sciences,  she  proceeded  in  2007  to  clinical  NEW GROUND
          medication  as  a  microbicide  to  prevent  HIV.
           Using  tenofovir  acquired  from  Gilead
          studies  of  this  antiretroviral  drug  in  a
          vaginally  applied  gel  formulation.   against  HIV  reached  54%  in  women  who   widely  recognised  by  her  peers.  Her
           The  ground-breaking  CAPRISA  004  trial,  used  the  gel  consistently  during  the  study.  numerous  awards  include  South  Africa’s
          which  she  led  as  co-principal  investigator,   Tenofovir  gel  is  the  first  medical   Order  of  Mapungubwe  Bronze  by  the
          involving  889  urban  and  rural  women  in   technology  shown  to  prevent  genital   President  of  South  Africa  and  the  Kwame
          South  Africa,  provided  proof-of-concept   herpes,  which  is  one  of  the  most  common   Nkrumah  Science  Award  by  the  AU.
          that  antiretrovirals  can  prevent  sexually   sexually  transmitted  infections  globally.  In  addition  to  her  research  contributions,
          acquired  HIV  infection  in  women.  Her   She  has  also  made  notable  contributions   Professor  Abdool  Karim  has  extensive
          research  showed  that  tenofovir  gel,  applied   that  go  beyond  HIV  prevention  to  addressing   policy  experience  that  stems  from  her  term
          before  and  after  sex,  reduced  HIV  incidence   one  of  the  biggest  challenges  in  Aids   as  the  first  national  director  of  the  South
          by  50%  after  12  months  of  gel  use  and  by   treatment  in  Africa  –  timing  of  antiretroviral   African  National  HIV/Aids  and  STD
          39%  overall,  at  the  end  of  the  30-month   therapy  initiation  in  TB-HIV  co-infected   Programme  that  was  established  by  the
          study.                              patients.                            Mandela  government  shortly  after  the
           The  protective  effect  of  tenofovir  gel   Her  scientific  contributions  have  been   country’s  first  democratic  elections  in  1994.

          6                                                                                         SCIENCE  IN  AFRICA
   1   2   3   4   5   6   7   8   9   10   11